Annabelle is a PhD student at the Kirby Institute, UNSW Sydney and is the Manager of the Hepatitis Policy Unit at NSW Health. Annabelle is passionate about using research to inform policies and improve healthcare access and outcomes.

Natasha Martin is a Professor in the Division of Infectious Diseases and Global Public Health, University of Califórnia San Diego. She holds a joint honorary professorship at University of Bristol.

I am Emmanuel Clement, a serial public health researcher with interest in HIV, hepatitis, TB and the well-being of key populations, especially people who inject drugs. I have had many abstracts accepted at international conferences like IAS and the HIV Prevention Conference in Munich and Peru, though I didn't have a scholarship to attend.

A Clinical Research Fellow in Hepatology with experience in clinical trials, community screening, outreach testing, outpatient management, and enhancing linkage to care for vulnerable populations.

Public Health Masters Student at London School of Hygiene and Tropical Medicine. Previously worked for Public Health Wales as a National point of care testing practitioner, working on the National viral Hepatitis and HIV elimination programme in Wales.

Andy Seaman (he/they) is an Associate Professor of Medicine at Oregon Health & Science University, the Medical Director of Hepatitis and HIV Services at Portland, Oregon's Central City Concern. He is boarded in addiction medicine. His research centers on the intersection of hepatitis C and injection drug use.

James O'Grady is a Research Coordinator with the Métropoles sans Hépatite C initiative in Montreal, Canada. He specializes in qualitative research and works closely with affected communities to ensure lived experiences inform program design and policy for hepatitis C elimination.

James OGrady is a research coordinator for Métropoles sans Hép C, an interdisciplinary initiative leading micro-elimination efforts in Montreal, Canada. James is passionate about community based research and is interested in the ways that individuals with HCV access health services.